$3.876
0.226[6.19%]
At close: May 20
$3.876
0[0.00%]
After Hours: 7:37AM EDT
Acumen Pharmaceuticals
(NASDAQ:ABOS)Latest News for Acumen Pharmaceuticals Stock (NASDAQ:ABOS)
Acumen Pharmaceuticals Stock (NASDAQ: ABOS)
Categories: All
Wednesday, May 15, 2024
Tuesday, May 14, 2024
Wednesday, May 08, 2024
Tuesday, April 16, 2024
Wednesday, March 27, 2024
Tuesday, March 26, 2024
- Acumen Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 EPS results.Benzinga Newsdesk - Mar 26, 2024, 12:41PM
- Acumen Pharmaceuticals Q4 EPS $(0.29) Misses $(0.26) EstimateHappy Mohamed - Mar 26, 2024, 9:28AM
- Acumen Pharmaceuticals FY23 EPS $(1.08) Down From $(1.06) YoY; Cash, Cash Equivalents And Marketable Securities $306.1MBenzinga Newsdesk - Mar 26, 2024, 7:08AM
- Earnings Scheduled For March 26, 2024Benzinga Insights - Mar 26, 2024, 4:47AM
Monday, March 25, 2024
Friday, March 08, 2024
- Acumen Pharmaceuticals Presents Sabirnetug Fluid Biomarker, Target Engagement Analyses From Phase 1 INTERCEPT-AD Study In Early Alzheimer's At AD/PD 2024 Annual MeetingBenzinga Newsdesk - Mar 8, 2024, 8:57AM
- Acumen Pharmaceuticals shares are trading higher after the company presented biomarker data from the ACU193 Phase 1 INTERCEPT-AD trial at the International Conference on Alzheimer's and Parkinson's Diseases.Benzinga Newsdesk - Mar 8, 2024, 8:52AM
Wednesday, February 21, 2024
Thursday, February 01, 2024
Tuesday, December 12, 2023
Monday, November 13, 2023
- Acumen Pharmaceuticals Secures $50.0M Credit Facility with K2 HealthVenturesBenzinga Newsdesk - Nov 13, 2023, 7:08AM
- Acumen Pharmaceuticals Q3 EPS $(0.24) Vs $(0.26) YoY, Cash Balance of $282.7M Likely to Support Current Clinical and Operational Activities into the Second Half of 2026Benzinga Newsdesk - Nov 13, 2023, 7:04AM
- Earnings Scheduled For November 13, 2023Benzinga Insights - Nov 13, 2023, 6:40AM
Friday, November 10, 2023
Monday, November 06, 2023
Wednesday, October 04, 2023
Wednesday, September 06, 2023
Wednesday, August 09, 2023
Tuesday, August 08, 2023
Monday, August 07, 2023
Wednesday, July 26, 2023
- Director At This Health Care Company Buys $40.00M of StockBenzinga Insights - Jul 26, 2023, 11:02AM
- $40M Bet On Acumen Pharmaceuticals? Check Out These 3 Stocks Insiders Are BuyingLisa Levin - Jul 26, 2023, 8:50AM
- Neuroinflammation A Key Indicator For Alzheimer's, But Current Treatments Show Little Success In Reducing Or Even Increase It — Could This Rising Company Have The Answer?David Willey - Sponsored
Thursday, July 20, 2023
Wednesday, July 19, 2023
Tuesday, July 18, 2023
- Acumen Pharmaceuticals shares are trading lower after the company announced a $100 million underwritten public offering.Benzinga Newsdesk - Jul 18, 2023, 3:21PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Jul 18, 2023, 1:31PM
- Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jul 18, 2023, 1:00PM
- Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving PremarketLisa Levin - Jul 18, 2023, 8:12AM
- Masimo, Acumen Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionLisa Levin - Jul 18, 2023, 6:46AM
Monday, July 17, 2023
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Jul 17, 2023, 5:32PM
- Acumen Pharmaceuticals Commence Public Offering Of $100M Of Shares Of Its Common StockBenzinga Newsdesk - Jul 17, 2023, 4:55PM
- Acumen Pharmaceuticals Plans To File A Preliminary Prospectus Supplement With The SEC For A Proposed Offering Of Common Stock, And As Of June 30, 2023, The Company Had Approximately $172.2M In Cash And Marketable SecuritiesHappy Mohamed - Jul 17, 2023, 4:50PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Jul 17, 2023, 1:31PM
- Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Jul 17, 2023, 1:14PM
- Ford Motor Cuts Prices For F-150 Lightning Truck, Microsoft-Sony Sign Agreement for 'Call of Duty,' Alibaba Stock Slips on China's Q2 GDP Sentiment: Today's Top StoriesVandana Singh - Jul 17, 2023, 10:13AM
- US Stocks Edge Higher; NY Empire State Manufacturing Index Falls In JulyLisa Levin - Jul 17, 2023, 10:01AM
- Cantor Fitzgerald Reiterates Overweight on Acumen Pharmaceuticals, Maintains $13 Price TargetBenzinga Newsdesk - Jul 17, 2023, 9:51AM